CrystecPharma listed as finalists for Innovation in Manufacturing Award at Making Pharmaceuticals


CrystecPharma listed as finalists for Innovation in Manufacturing Award at Making Pharmaceuticals - Image


Crystec are delighted to announce that their mSAS (modified Supercritical Anti-Solvent) technology has been shortlisted for the Making Pharmaceuticals Innovation in Manufacturing Award.

Making Pharmaceuticals is the UK’s leading pharmaceutical exhibition and conference with over 200 companies exhibiting their latest products and services. The event attracts over 2,000 visitors, delegates and speakers to create a valuable networking opportunity. This year’s event takes place at the Ricoh Arena, Coventry, from 30th April - 1st May, where Crystec Research Scientist, Ben Leeming, will present work on pharmaceutical co-crystals, their development and applications.

Crystec have been named as finalists for the Innovation in Manufacturing Award for their mSAS (modified Supercritical Anti-Solvent) technology, a powerful crystallisation and particle engineering platform that allows precise control over particle formation, to design performance into particles, enhancing product performance. Winners will be announced at an awards ceremony on 30th April.

If you are attending Making Pharmaceuticals and would like to learn more about mSAS, please get in touch with Emily (emily.bevis@crystecpharma.com) to schedule a meeting, or visit us at stand 233